Fadel, A.; Nithura, J.; Saadoon, Z.F.; Naseer, L.; Lopez-Lacayo, A.; Rojas Solano, L.E.; Palau Morales, C.; Hernandez, R.J.; Hussain, H.
Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease. Dermatopathology 2025, 12, 17.
https://doi.org/10.3390/dermatopathology12020017
AMA Style
Fadel A, Nithura J, Saadoon ZF, Naseer L, Lopez-Lacayo A, Rojas Solano LE, Palau Morales C, Hernandez RJ, Hussain H.
Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease. Dermatopathology. 2025; 12(2):17.
https://doi.org/10.3390/dermatopathology12020017
Chicago/Turabian Style
Fadel, Aya, Jayakumar Nithura, Zahraa F. Saadoon, Lamia Naseer, Angelo Lopez-Lacayo, Ligia Elena Rojas Solano, Chaveli Palau Morales, Robert J. Hernandez, and Hussain Hussain.
2025. "Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease" Dermatopathology 12, no. 2: 17.
https://doi.org/10.3390/dermatopathology12020017
APA Style
Fadel, A., Nithura, J., Saadoon, Z. F., Naseer, L., Lopez-Lacayo, A., Rojas Solano, L. E., Palau Morales, C., Hernandez, R. J., & Hussain, H.
(2025). Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease. Dermatopathology, 12(2), 17.
https://doi.org/10.3390/dermatopathology12020017